Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology
News Ticker
- [ March 21, 2023 ] Senior Scientist – Adaptive Biotechnologies – South San Francisco, CA San Francisco Biotech Jobs
- [ March 21, 2023 ] SRA/ Associate Scientist, Cell Therapy – Slingshot Biosciences – Emeryville, CA San Francisco Biotech Jobs
- [ March 21, 2023 ] Corporate Counsel – Slingshot Biosciences – Emeryville, CA San Francisco Biotech Jobs
- [ March 21, 2023 ] Tech Transfer Associate/Scientist – Slingshot Biosciences – Emeryville, CA San Francisco Biotech Jobs
- [ March 21, 2023 ] Research Technician/ Associate – Slingshot Biosciences – Emeryville, CA San Francisco Biotech Jobs
Copyright © 2022 Biotech Networks, LLC
